CA3212248A1 - Improved methods of treating diseases resulting from a maladapted stress response - Google Patents
Improved methods of treating diseases resulting from a maladapted stress response Download PDFInfo
- Publication number
- CA3212248A1 CA3212248A1 CA3212248A CA3212248A CA3212248A1 CA 3212248 A1 CA3212248 A1 CA 3212248A1 CA 3212248 A CA3212248 A CA 3212248A CA 3212248 A CA3212248 A CA 3212248A CA 3212248 A1 CA3212248 A1 CA 3212248A1
- Authority
- CA
- Canada
- Prior art keywords
- crfr2
- agonist
- maladaptation
- ct38s
- dose
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2228—Corticotropin releasing factor [CRF] (Urotensin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Endocrinology (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163200609P | 2021-03-17 | 2021-03-17 | |
| US63/200,609 | 2021-03-17 | ||
| PCT/US2022/071209 WO2022198230A1 (en) | 2021-03-17 | 2022-03-17 | Improved methods of treating diseases resulting from a maladapted stress response |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3212248A1 true CA3212248A1 (en) | 2022-09-22 |
Family
ID=83320930
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3212248A Pending CA3212248A1 (en) | 2021-03-17 | 2022-03-17 | Improved methods of treating diseases resulting from a maladapted stress response |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20250319161A1 (https=) |
| EP (1) | EP4308150A4 (https=) |
| JP (1) | JP2024511066A (https=) |
| AU (1) | AU2022238570A1 (https=) |
| CA (1) | CA3212248A1 (https=) |
| WO (1) | WO2022198230A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN117618528B (zh) * | 2023-12-01 | 2024-10-01 | 广东医科大学 | 一种方格星虫多肽srp及其在制备治疗急性肾损伤药物中的应用 |
| TW202544027A (zh) * | 2024-04-19 | 2025-11-16 | 美商紐羅克里生物科學有限公司 | 促皮質素釋放因子受體２（ｃｒｆｒ２）促效劑 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110105397A1 (en) * | 2009-11-04 | 2011-05-05 | Gengo Peter J | Method for treating heart failure with stresscopin-like peptides |
| KR20190084055A (ko) * | 2016-10-20 | 2019-07-15 | 코르텐 인코포레이티드 | 부적응 스트레스 반응에서 기인한 질환의 치료 방법 |
-
2022
- 2022-03-17 US US18/550,798 patent/US20250319161A1/en active Pending
- 2022-03-17 JP JP2023557667A patent/JP2024511066A/ja active Pending
- 2022-03-17 EP EP22772386.3A patent/EP4308150A4/en active Pending
- 2022-03-17 AU AU2022238570A patent/AU2022238570A1/en active Pending
- 2022-03-17 CA CA3212248A patent/CA3212248A1/en active Pending
- 2022-03-17 WO PCT/US2022/071209 patent/WO2022198230A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022238570A1 (en) | 2023-09-28 |
| EP4308150A4 (en) | 2025-02-19 |
| US20250319161A1 (en) | 2025-10-16 |
| JP2024511066A (ja) | 2024-03-12 |
| WO2022198230A1 (en) | 2022-09-22 |
| EP4308150A1 (en) | 2024-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2330671T3 (es) | Amilina y agonistas de amilina para el tratamiento de enfermedades y trastornos psiquiatricos. | |
| US11648295B2 (en) | Methods of treating diseases resulting from a maladapted stress response | |
| US20250319161A1 (en) | Improved methods of treating diseases resulting from a maladapted stress response | |
| TW202417035A (zh) | 提派肽(tirzepatide)組合物及用途 | |
| Gregoretti et al. | Clonidine in perioperative medicine and intensive care unit: more than an anti-hypertensive drug | |
| AU2006341375B2 (en) | Amylin and amylin agonists for treating psychiatric diseases and disorders | |
| Abboud et al. | Essential tremor: choosing the right management plan for your patient | |
| Rylkova et al. | Effects of NPY and the specific Y1 receptor agonist [D-His26]-NPY on the deficit in brain reward function and somatic signs associated with nicotine withdrawal in rats | |
| JP6567971B2 (ja) | 女性性機能障害の治療におけるブレメラノチドの使用 | |
| US20090181890A1 (en) | Amylin and Amylin Agonists for Treating Psychiatric Diseases and Disorders | |
| RU2655763C2 (ru) | Фармацевтическая композиция и способ лечения женских сексуальных дисфункций | |
| Yadav | A Comparative Study of Efficacy of Lignocaine (1.5 mg/Kg) Versus Dexmedetomidine (1 µg/Kg) in Attenuating Haemodynamic Response to Laryngoscopy and Endotracheal Intubation–A Clinical Study | |
| WO2005070437A1 (ja) | 疼痛の治療のための医薬 | |
| Raffaeli et al. | Intrathecal drug administration for the treatment of cancer and non-cancer chronic pain |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250307 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT Effective date: 20250307 Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250307 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED Effective date: 20260219 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20260219 |
|
| D00 | Search and/or examination requested or commenced |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D00-D118 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION REQUIREMENTS DETERMINED COMPLIANT Effective date: 20260305 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-2-D10-D11-D155 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: ALL REQUIREMENTS FOR EXAMINATION DETERMINED COMPLIANT Effective date: 20260305 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-2-2-W10-W00-W100 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: LETTER SENT Effective date: 20260305 |